CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Prevalence of hepatitis b and hepatitis c at phi clinical hospital bitola in 2018

Author: 
Vladimir Radevski, Biljana Ilkovska, Ana Marija Radevska, Bisera Kotevska Trifunova, Aleksandar Dimovski, Sandra Hristovska and Marina Ivanovska
Subject Area: 
Health Sciences
Abstract: 

Introduction: Hepatitis B infection is a common cause of chronic liver disease. The World Health Organization estimates that 257 million people are living with hepatitis B. In 2015, over 800,000 deaths worldwide were attributed to complications of hepatitis B infection. Hepatitis C virus is a globally prevalent pathogen and a leading cause of death and morbidity, is a major cause of cirrhosis and hepatocellular carcinoma. The most recent estimates of disease burden show an increase in seroprevalence over the last 15 years to 2.8%, equating to >185 million infections worldwide. Materials and Methods: This study was carried at the Department of medical biochemistry in Public Health Organization Clinical hospital d-r Trifun Panovski in Bitola. The serum was separated and HCV and HBs Ag were measured using Abbot Architect CI 4100 analyzer. Results: A total of 661 patients were examineated. The mean age of the cohort was 41 years old, ranging from 0 to 90 years old. Analysis of the results showed that 129 patients were reactive of the virus: 43 patients are HBsAg reactive (22 males and 21 females), 81 patients are anti-HCV reactive (65 males and 16 females), 4 patients are HBsAg + anti-HCV reactive (male). Discusion: In our country the rate of HCV and HBV cases is constantly increasing. This is evidenced by data from our research showing a 1% increase in cases compared to 2016. Seriously worrying is the fact that in 2018 there are 30 more patients, newly infected with hepatitis C virus. Hepatitis B virus has been proven to have several subtypes, but unfortunately it has not yet been detected in our country. Conclusion: Hepatitis B and C infections are a serious health and social problem. They affect the quality of life of the whole family, not just the person who carries the disease. It is necessary to educate the population at an early age on how to transmit and direct young people to healthy lifestyles, sports and contraceptive use.

PDF file: 

CALL FOR PAPERS

 

ONLINE PAYPAL PAYMENT

IJMCE RECOMMENDATION

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

EDITORIAL BOARD

CHUDE NKIRU PATRICIA
Nigeria
Dr. Swamy KRM
India
Dr. Abdul Hannan A.M.S
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran